During the past decade, Cardiovascular Center Aalst conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Center Aalst" #1 sponsor was "Celyad Oncology SA" with 1 trials, followed by "Clinical Centre of Serbia" with 1 trials sponsored, "HeartFlow, Inc." with 1 trials sponsored, "Micell Technologies" with 1 trials sponsored and "NHS National Waiting Times Centre Board" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Center Aalst" #1 collaborator was "Catharina Ziekenhuis Eindhoven" with 2 trials as a collaborator, "Golden Jubilee National Hospital" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Brno University Hospital" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Center Aalst" are "Coronary Artery Disease" (4 trials), "Aortic Stenosis" (1 trials), "Coronary Disease" (1 trials), "Coronary Stenosis" (1 trials) and "Heart Failure Class II or III" (1 trials). Many other conditions were trialed in "Cardiovascular Center Aalst" in a lesser frequency.

Most popular intervention types in "Cardiovascular Center Aalst" are "Device" (3 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "C-Cure" (1 trials), "CABG" (1 trials), "Endeavor DES" (1 trials), "FFR guided PCI" (1 trials) and "Fantom Sirolimus-Eluting Coronary Bioresorbable Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Center Aalst" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Center Aalst". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Cardiovascular Center Aalst, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Center Aalst, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".